17
Dec

Johnson & Johnson has signed a deal to use Halozyme Therapeutics’ drug delivery platform in its own R&D efforts, agreeing to pay as much as $581 million for the privilege.

…read more

Source: J&J rents Halozyme’s R&D technology for up to $581M

    

0 No comments